Scripps Research in La Jolla announce a new clinical trial that will assess the effectiveness of using drugs approved for diabetes treatment and weight loss to treat long COVID-19, the debilitating chronic condition diagnosed in an estimated 20 million Americans and about 400 million people worldwide.
This article was originally published on MedicalXpress.com

